SANXING(SH:601567) Sou Hu Cai Jing·2025-07-26 22:26Core Viewpoint - Samsung Medical (601567) has shown a positive stock performance with a closing price of 22.18 yuan, reflecting a 3.16% increase from the previous week, indicating strong market interest and potential growth opportunities [1] Company Announcements - Samsung Medical's subsidiary, Brazil Nansen, has won a procurement framework contract for transformers with CPFL Energia SA in Brazil, amounting to 3.41 billion yuan, which is expected to positively impact the company's operational performance and is projected to account for 2.33% of the audited revenue for 2024 [1] - The company has provided guarantees for its subsidiaries, including a guarantee of 100,000 USD (approximately 716,200 yuan) for Ningbo Aux Intelligent Technology Co., Ltd. and a guarantee of 69,000 USD (approximately 496,200 yuan) for Brazil Nansen, with total external guarantees amounting to 974.85 million yuan, representing 80.69% of the latest audited net assets [2]